Dermatological toxicity of EGFR inhibitors: pathogenetic rationale and an algorithm for acne-like rash correction
Therapy with epidermal growth factor receptor (EGFR) inhibitors is inevitably accompanied by the phenomena of dermatological toxicity. Being, on the one hand, a favorable prognostic factor for the effectiveness of anticancer therapy, these adverse events are one of the most frequent indications for...
Saved in:
| Main Authors: | A. V. Michenko, L. S. Kruglova, E. A. Shatokhina, I. B. Kononenko, A. S. Polonskaya, D. V. Romanov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2021-11-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/504 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acneiform rash — skin toxic reaction to the use of EGFR inhibitors
by: E. A. Shatokhina, et al.
Published: (2019-01-01) -
Dermatologic adverse events associated with epidermal growth factor receptor inhibitors: current concepts of interdisciplinary problem
by: A. S. Polonskaia, et al.
Published: (2022-02-01) -
Flagellate Rash in Chikungunya: A Comprehensive Review of Dermatological Manifestations
by: Nikhil Mehta, et al.
Published: (2025-07-01) -
Antipsychotics and rashes
by: Jessica Lin
Published: (2018-11-01) -
Efficacy and safety of systemic spironolactone for acne in female patients in Sulaymaniyah teaching center of dermatology
by: Soma Khasrow Abdullah, et al.
Published: (2024-09-01)